Top

Current Atherosclerosis Reports

Content (8 Articles)

Coronary Heart Disease

What Is the Optimal Duration of Antiplatelet Therapy for Patients with Coronary Heart Disease?

Beryl Otieno, Chukwuka Ibecheozor, Marlene S. Williams

Positron Emission Tomography

The Role of Cardiac PET in Diagnosis and Prognosis of Ischemic Heart Disease: Optimal Modality Across Different Patient Populations

Malek Nayfeh, Ahmed Ibrahim Ahmed, Jean Michel Saad, Fares Alahdab, Mouaz Al-Mallah

Insulins

The Pandemic of Coronary Heart Disease in South Asia: What Clinicians Need to Know

Kartik Gupta, Farhala Baloch, Tanya S. Kakar, Harsh Agarwal, Bharat Rawlley, Unab I. Khan, Romaina Iqbal, Rubina Barolia, Salim S. Virani

Open Access Stroke

Eggs and Cardiovascular Disease Risk: An Update of Recent Evidence

Sharayah Carter, Elizabeth S. Connole, Alison M. Hill, Jonathan D. Buckley, Alison M. Coates

PCSK9 Inhibitor

In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show?

Mario Enrico Canonico, Connie N. Hess, Christopher P. Cannon

Hypercholesterolemia

Lipoprotein Apheresis: Current Recommendations for Treating Familial Hypercholesterolemia and Elevated Lipoprotein(a)

Maya S. Safarova, Patrick M. Moriarty

Obesity

Childhood Obesity and Cardiovascular Disease Risk

Stephanie T. Chung, Andrea Krenek, Sheela N. Magge

Hypertension

Double-Trouble: Atherosclerotic Risk Factors and Congenital Heart Disease

Justin P. Zachariah

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.